跳到正文

Flynn James E 内部人交易：近期 SEC Form 4 交易

过去 18 个月，Flynn James E（CIK 1352546）在 4 家公司共报告 28 笔 SEC Form 4 内部人交易（最近一笔 2026-07-17）。

日期公司身份类型股数市值
2026-07-17Nuvalent, Inc. (NUVL)董事卖出8.3M$1.03B
2026-07-17Nuvalent, Inc. (NUVL)董事卖出8.3M$1.03B
2026-07-17Nuvalent, Inc. (NUVL)董事卖出650,000$80.6M
2026-07-17Nuvalent, Inc. (NUVL)董事卖出5,146$638,104
2026-07-17Nuvalent, Inc. (NUVL)董事卖出5,146$638,104
2026-07-17Nuvalent, Inc. (NUVL)董事卖出3,444$427,056
2026-06-18Nuvalent, Inc. (NUVL)董事买入3,444$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入260,992$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入122,990$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入149,238$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入149,238$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入260,992$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入122,990$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入407,132$0
2026-06-11Parabilis Medicines, Inc. (PBLS)10% 以上股东买入407,132$0
2026-03-02Larimar Therapeutics, Inc. (LRMR)董事买入1.1M$5.4M
2026-03-02Larimar Therapeutics, Inc. (LRMR)董事买入1.1M$5.4M
2026-03-02Larimar Therapeutics, Inc. (LRMR)董事买入831,978$4.2M
2026-03-02Larimar Therapeutics, Inc. (LRMR)董事买入2.0M$10.0M
2025-11-24Nuvalent, Inc. (NUVL)董事卖出371,287$35.4M
2025-11-24Nuvalent, Inc. (NUVL)董事卖出371,287$35.4M
2025-08-04Larimar Therapeutics, Inc. (LRMR)董事买入3.4M$10.8M
2025-08-04Larimar Therapeutics, Inc. (LRMR)董事买入3.4M$10.8M
2025-08-04Larimar Therapeutics, Inc. (LRMR)董事买入2.6M$8.3M
2025-07-01ARS Pharmaceuticals, Inc. (SPRY)10% 以上股东卖出370,075$6.8M

来源：SEC Form 4 申报文件 · 截至 2026-07-17